Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Intersect Ent Inc (XENT)

Intersect Ent Inc (XENT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Real-World Evidence Study Demonstrates Intersect ENT’s PROPEL® Sinus Implant Reduces Healthcare Resource Utilization

Intersect ENT ® , Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced positive results of an observational,...

XENT : 28.24 (unch)
Orthofix Announces Appointment of Thomas A. West to Board of Directors

Orthofix Medical Inc . (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced that Thomas A. West has been named to the Company’s Board of Directors and appointed...

OFIX : 17.53 (-1.68%)
XENT : 28.24 (unch)
Intersect ENT: Q3 Earnings Snapshot

MENLO PARK, Calif. (AP) _ Intersect ENT Inc. (XENT) on Tuesday reported a loss of $31.8 million in its third quarter.

XENT : 28.24 (unch)
Intersect ENT Reports Third Quarter 2021 Financial Results

Intersect ENT, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today reported financial results for the third quarter ended...

XENT : 28.24 (unch)
First Implants of PROPEL® Contour in Patients with Chronic Rhinosinusitis Following Frontal Sinus Surgery in Europe

Intersect ENT®, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced that Helios Dr. Horst Schmidt Kliniken...

XENT : 28.24 (unch)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates XENT, INOV, SAFM, HOMB; Shareholders are Encouraged to Contact the Firm

NEW YORK, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

XENT : 28.24 (unch)
INOV : 28.78 (-0.12%)
SAFM : 204.00 (-2.51%)
HOMB : 28.41 (-1.25%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates SBKK, SAFM, LMRK, XENT; Shareholders are Encouraged to Contact the Firm

NEW YORK, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

SBKK : 18.5800 (+1.03%)
SAFM : 204.00 (-2.51%)
LMRK : 16.49 (+0.30%)
XENT : 28.24 (unch)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates INOV, LMRK, XENT, JAX; Shareholders are Encouraged to Contact the Firm

NEW YORK, NY / ACCESSWIRE / September 13, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Inovalon Holdings, Inc. (NASDAQ: INOV) concerning...

INOV : 28.78 (-0.12%)
LMRK : 16.49 (+0.30%)
XENT : 28.24 (unch)
JAX : 14.00 (+0.14%)
Lifshitz Law Firm, P.C. Announces Investigation of INOV, XENT, LMRK, and GTS

NEW YORK, Sept. 11, 2021 (GLOBE NEWSWIRE) --

INOV : 28.78 (-0.12%)
XENT : 28.24 (unch)
LMRK : 16.49 (+0.30%)
GTS : 35.99 (+1.04%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates INOV, GTS, XONE, XENT; Shareholders are Encouraged to Contact the Firm

NEW YORK, NY / ACCESSWIRE / September 4, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Inovalon Holdings, Inc. (NASDAQ:INOV) concerning...

INOV : 28.78 (-0.12%)
GTS : 35.99 (+1.04%)
XONE : 49.68 (+0.06%)
XENT : 28.24 (unch)

Barchart Exclusives

Is Rumble Stock a Buy, Sell, or Hold After a $775 Million Investment?
Rumble’s stock has shot up following an investment agreement with a giant crypto firm. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar